CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysis.
Aikaterini TheodorouIoanna TsantzaliMaria-Ioanna StefanouSimona SaccoAristeidis H KatsanosAshkan ShoamaneshTheodoros KarapanayiotidesIoanna KoutroulouPolyxeni StamatiDavid J WerringCharlotte CordonnierLina PalaiodimouChristina ZompolaEfstathios BoviatsisLampis StavrinouFrantzeska FrantzeskakiThorsten SteinerAndrei V AlexandrovGeorgios P ParaskevasGeorgios K TsivgoulisPublished in: European stroke journal (2024)
CAA is characterized by a distinct CSF biomarker pattern compared to HC and AD. CSF Aβ40 levels are lower in CAA compared to HC and AD, while tau and p-tau levels are higher in CAA compared to HC, but lower in comparison to AD patients.